DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) is scheduled to post its quarterly earnings results after the market closes on Tuesday, March 28th. Analysts expect DiaMedica Therapeutics to post earnings of ($0.14) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link. DiaMedica Therapeutics […]
Related Keywords
, Dimensional Fund Advisors , Diamedica Therapeutics Company Profile , Renaissance Technologies , Citadel Advisors , Diamedica Therapeutics Inc , Diamedica Therapeutics , Get Rating , Medica Therapeutics , Fund Advisors , Street Corp , Jane Street Group , Street Group , Wayne Lautt , Diamedica Therapeutics Daily , Nasdaq Dmac , Sdmac , Medical , Earnings ,
vimarsana.com © 2020. All Rights Reserved.